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Abstract 
In this study, attempts were made to develop computer controlled iontophoretic drug delivery 
system. The iontophoretic set up was made using NI SPEEDY33 voltage buffer, constant current 
source and specially designed diffusion cell. The stability of constant current source was checked 
by varying the load resistance and measured the voltage across it. Different wave forms were 
generated using NI SPEEDY 33 and LABVIEW 8.6 and they were employed in the in vitro drug 
delivery. The effectiveness of iontophoretic set up was tested using span 80-tween 80 based 
sunflower oil organogels. The organogels were characterized using SEM, FTIR and XRD 
studies. Thermal, textural, visco-elastic and electrochemical properties of the organogels were 
also studied. The in vitro drug release studies were performed using different wave forms viz., 
sinusoidal waveform ,square waveform and triangular waveform. and also the half wave and full 
wave of sine waveform . The active drug release from the gels was compared against passive 
diffusion. The drug release followed the zero order kinetics suggesting the diffusion mediated 
release. The Krossmeyer-Peppas kinetics suggested the anomalous release of drugs during active 
diffusion of drugs. The results suggest that the developed iontophoretic set up has a huge 
potential in the iontophoretic drug delivery system. 
Keywords: NI SPEEDY 33 , LABVIEW 8.6 , iontophoresis, organogels 
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Introduction and objective 
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1 Introduction 
Skin is the largest organ and the integumentary system of the body [1]. It has been explored to 
deliver drugs either to elicit pharmacological actions locally or systemically [2]. The delivery of 
drugs into the systemic circulation across the skin is regarded as transdermal delivery. The main 
advantage of transdermal drug delivery is by passing the first pass metabolism by the drug 
molecules. But the migration of drug from the skin surface into the systemic circulation is the 
rate-limiting step. Many approaches (e.g. use of permeation enhancers, electrical energy, 
ultrasound or a combination of these) have been adopted to improve the permeation of the drugs 
through the skin layer [2]. Amongst the techniques studied, iontophoretic drug delivery system 
has evolved as one of the widely studied transdermal drug delivery systems. Iontophoresis is a 
non-invasive transdermal drug delivery methodology which uses a low intensity electric current 
to promote permeation of the drug across the skin[3]. The method is based on the phenomenon 
of like charges repel each other. The technique uses a two electrode system. One of the 
electrodes is the active electrode while the other is the passive electrode. The drug molecules 
used for iontophoretic drug delivery are usually charged molecules. But various neutral drug 
molecules have also been tried. If the drug molecules are anionic in nature then cathode is made 
the active electrode and vice versa. The delivery of the drug has been found to be dependent on 
the profile of the electric current applied. Various current profiles have been applied and their 
effect on the release profile has been studied extensively. 
Drugs are usually incorporated within gel based matrices. The drug loaded matrices are placed in 
the donor compartment. The matrices should be electrically conductive in nature. Till recent past, 
only hydrogels were regarded as suitable for iontophoretic delivery systems. Hydrogels are 
polymeric matrices which can imbibe and hold water within the polymeric structures. Of late, 
water containing organogels have also been tried as drug delivery matrices for iontophoretic drug 
delivery systems. Organogels are gel based systems which immobilizes apolar solvents. In 
general, organogels are electrically non-conductive. Organogel based formulations may be 
designed to contain pockets of water, which can make the organogels electrically conductive. 
The development of organogels is much easier as compared to the hydrogels. Organogel based 
delivery systems have shown good potential to be used in iontophoretic drug delivery systems. 
The current study deals with the development of a computer controlled iontophoretic drug 
delivery system. In our previous study, we have reported development of span 80- tween 80 
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based organogels. Three compositions of organogels were chosen and were analyzed for their 
ability to act as matrices for iontophoretic drug delivery. 
1.2. Objective 
Development of computer controlled iontophoretic drug delivery system. 
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2.1. Iontophoretic drug delivery 
Iontophoresis is a technique to deliver the drug or other chemical through the skin with the help 
of small electric charge [4]. It is important because of without injection of needle. This process is 
also called a non invasive method of propelling high concentrations of charged substances. The 
non invasive nature of the method has led to the increase in the patient compliance. Iontophoresis 
is well classified for use in transdermal drug delivery with more recent investigations focusing 
on applications such as sweat testing for the diagnosis of cystic fibrosis, hyperhidrosis, local 
anesthesia, and for ulcers. Additionally, over the last few decades, iontophoresis has come to be 
used as a technique researched primarily for its use in the delivery of charged ions and 
macromolecules through the skin for systemic circulation [5]. iontophoresis provides a non-
invasive method for the delivery of agent at therapeutically significant  level due to its 
enhancement effect on skin permeation. These benefits are specially significant for 
administration of protein and peptides which do not achieve therapeutically significant 
concentrations by the oral delivery route. This technique allows the effective delivery of drugs 
with short biological half lives, as it shortens the time frame from administration to delivery the 
target tissue. Patient compliance is significantly improve due to infrequent dosing, and treatment 
can be terminated when needed. The advantage of this technique are accompanied by limitation 
of procedure, the most obvious being the potential for burning and pain on application of electric 
current. This technique is considered safe, if increasing the intensity of the applied electric 
charge can be led to irritation, burning , necrosis and erythema etc. an iontophoresis is usually 
restricted to compounds that can be formulated in their ionic form. In case of ionic compound, 
the pH of the skin is not the same in deeper layer as it is at the surface. This may lead to 
ineffective iontophoresis for some molecules due the effect of pH on ionization. Here this 
phenomenon related with proteins and peptides where the charge is an important factor in their 
delivery and stability. The effective iontophoretic transport of charged species may also be 
affected by an ion competition factor due to the presence of other moieties and also the 
degradation or adsorption of the drug under the electrode. 
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2.2. Operational amplifier 
IC OP07 is an op amp which is used for both inverting and non-inverting amplification and for 
many more applications such as constant current source, voltage buffer, current mirror etc. gain 
(AV) in non inverting mode = 1+ (R2 / R1) and inverting mode = (-R2/R1) [6]. Pin configuration 
has been given in figure 1. 
 
Figure 1: Pin configuration of OP07 
2.3. NI SPPEEDY 33 
The SPEEDY-33 is an educational Digital Signal Processing development board that is easily 
programmed using the LABVIEW DSP Module [7]. SPEEDY33 stands for signal processing 
educational engineering device for youth. The number 33 comes from the DSP chip 
TMS320VC33 made by Texas Instruments. The TMS320VC33 operates at 150MHz. here we are 
using SPEEDY-33 as a waveform generator.  The figure of SPEEDY 33 has been given below. 
 
Figure 2: SPEEDY 33 
2.4. Constant current source 
The constant current source is circuit which sinks or sources a constant current regardless of 
changing load resistance or power supply voltage [8]. The constant current source is needed to 
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supply invariant current with varying load, temperature and input voltage. the constant current 
source is used for impedance measurement, converts the sinusoidal voltage to current which is 
unaffected by load [9]. There are different techniques for implementing the voltage controlled 
voltage source (VCCS) for measuring bioimpedance: VCCS using an inverting amplifier, 
transformer coupled op amp, Howland configuration of op amp, current mirror based current 
source. 
2.5. VCCS using an inverting amplifier 
The voltage controlled current source (VCCS) using single op amp inverting amplifier is the 
simplest method to implement. In this method, the load resistance is connected to the feedback 
path of the amplifier. This constant current source can be used in the delivery of the drug into the 
body [10]. 
2.6. Howland constant current source 
The Howland constant current source is a current source which is used to implement differential 
current source. This type of current source is implemented connecting two current sources in 
series [11]. 
In this type of current source balance should be maintained to between the two current sources. If 
any imbalance of parameter occurs in the current sources of Howland current source, it may 
cause a non-nominal value of current injected through the sample and common mode signal. 
2.7. Current mirror based constant current source 
Current mirror based constant current source is more advantageous than the other type of VCCS 
as it has high output impedance. It consists of a current generator, a current mirror and a current 
regulator [12]. Current mirror circuit with high precision has highly accurate current ratio and it 
prevents variation of output voltage due to its high output impedance. 
2.8. Rectifier 
Rectifier is an electrical device that converts alternating current to direct current. It is only one 
directional flows. This process is called rectification. Present day it take a number of forms  
including solid state diode, SCR and other silicon based semiconductor switches. 
16 
 
 
2.8.1. Half wave rectifier 
In the half wave rectification circuit either positive or negative half of AC wave is passed, while 
the other half is blocked. It depends only on diode conditions. It can be used to obtain the desired 
value of dc voltage it has also provides a isolation from the power line [13]. The half wave 
circuit diagram shown in figure 3. 
 
Figure 3: Circuit diagram of half wave rectifier 
2.8.2. Full wave rectifier 
The full wave rectifier circuit converts the whole of the input wave form to one of constant 
polarity as its output. Full-wave rectifier circuit converts both polarities of the input waveform to 
DC and yields a higher mean output voltage [14]. The circuit diagram of full wave rectifier 
shown in figure 4. 
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Figure 4: Circuit diagram of full wave rectifier 
2.9. Organogels 
Gel is nothing but it is colloid suspension of solid particles. It is a semisolid system, by the three 
dimensional (self-assembled, intertwined gelator fibers) network the liquid phase is immobilized, 
despite the majority of liquid composition it demonstrate the appearance and rheological 
behaviour of solids. In last few decades Investigative research pertaining to these systems [15]. A 
various application of the organogels such as drug delivery mediums for topical and oral 
pharmaceuticals, organic application medium for cosmetics, cleaning material for art 
conservation, delivery nutrient or neutraceuticals (vitamins and supplements), particale in 
personal core product (shampoo, conditioner), crystalline fat in food processing etc. 
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Chapter 3 
Materials and methods 
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3.1. Materials 
IC OP07 was procured from Analog Devices, Noorwood, USA. SPEEDY 33 was procured from 
National instruments, USA. Other basic electronic components were procured from the local 
market. Span 80 (sorbitan monooleate; SM) was purchased from Loba Chemie, Mumbai, India. 
Tween 80 (polyoxyethylene sorbitan monooleate; PM) and Sodium salicylate (SA) were 
purchased from Hi-media, Mumbai, India. The stainless steel (SS) electrodes for the 
iontophoretic studies were fabricated from the high quality SS plates procured from the local 
market. Edible grade refined sunflower oil (SO) was procured from the local market. All the 
studies were conducted using double distilled water (DW). 
3.2. Circuit development 
The basic waveforms (e.g. sine, triangular and square) were generated using computer controlled 
SPEEDY-33. The output from the SPEEDY-33 was connected to a voltage buffer (to protect the 
SPEEDY-33) followed by a signal conditioning circuit (SCC) to modulate the basic waveforms 
as desired. The SCC was avoided if the basic waveform was to be used. The setup of computer-
SPEEDY-33-SCC acted as a waveform generator (WG). The output of the WG was connected to 
an OPAMP based voltage-controlled constant current source (CCS) working in the inverting 
amplification mode. The CCS was connected with the 2 electrode system. Depending on the 
polarity of the electrodes, one of the electrodes served as the active electrode while the other 
electrode was used as the passive electrode. These electrodes were connected to the specially 
designed diffusion cell, which contained a drug reservoir, a receptor and a dummy reservoir 
(Figure 5). The schematic diagram of the complete setup has been shown in (figure 6)  
20 
 
 
Figure 5: Block diagram of the Franz diffusion cell 
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Figure 6: Block diagram of iontophoretic drug delivery system 
3.3 Signal conditioning circuit (SCC) 
The basic waveform signals from the voltage buffer were fed into the SCC. The SCC was either 
precision half-wave rectifier or precision full-wave rectifier. The SCC has been designed as per 
the previously reported literature. The circuit diagrams of the SCCs have been shown in figures 7 
and 8. The proper functioning of the SCCs was tested by applying the basic waveforms into the 
SCCs and monitoring the output of the SCCs.  
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Figure 7: Circuit diagram of half wave rectifier 
 
 
Figure 8: Circuit diagram of full wave rectifier 
3.4. Designing of Constant current source circuit (CCS)  
CCS was designed using IC OP07 working in the inverting amplifier mode (figure 9). The output 
of the voltage buffer was fed into the inverting terminal of the IC OP07 through a variable 
resistance (R1: 10 KΩ). R1 was chosen from the previously conducted impedance measurement 
studies. The stability of the CCS was studied by varying the load resistance and measured the 
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output voltage across it. The circuit diagram of constant current source has been shown in figure 
9. 
 
Figure 9: Circuit diagram of constant current source 
3.5. Preparation of organogels 
The preparation of the organogels was carried out by fluid filled fiber mechanism as per the 
previously reported literature [16]. Surfactant mixture of SM-PM (1:2 weight ratio) was used as 
the organogelator. The organogels were prepared by altering the compositions of SM-PM, SO 
and DW. The compositions of the selected organogels have been provided in table 1. Briefly, 
SM-PM mixture was dissolved in SO and subsequently homogenized using magnetic stirrer (100 
rpm) at room-temperature (RT, 25 
o
C). To this homogenized solution, DW was added drop-wise 
with continuous vortexing. After the addition of DW, the mixture was vortexed further for 3 min. 
Drug (SA) containing organogels were prepared by using SA solution in DW as the aqueous 
phase. The final concentration of the drug was maintained as 0.5% w/w in all the gels. 
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Table 1: Composition of the organogels 
Samples Composition % (w/w) SA % (w/w)  
SM DW SO 
F1 50.0 20.0 30.0 -- 
F2 60.0 20.0 20.0 -- 
F3 50.0 30.0 20.0 -- 
F1D 49.5 20.0 30.0 0.5 
F2D 59.5 20.0 20.0 0.5 
F3D 49.5 30.0 20.0 0.5 
3.6. Impedance measurement 
The electrical properties of the organogels were measured using a computer-controlled 
impedance analyzer (Phase sensitive multimeter, Model: PSM1735, Numetriq, Japan) in the 
frequency range of 0.1Hz–1.0 MHz  
3.7. In vitro drug delivery 
The drug delivery studies were performed using a specially designed diffusion cell (figure 5). SS 
electrodes (diameter: 2 cm) were used as the electrode and were connected to the donor and the 
dummy chambers. The donor chamber contained drug loaded organogel while the dummy 
chamber contained normal saline (figure 5). The donor and the receptor chambers were separated 
from the receptor chamber using a pre-activated dialysis membrane. The experimental set up of 
the iontophoretic drug delivery system has been shown in figure 10. The current flowing through 
the system was 1.06 mA, which provided a current density of 0.048 μA/cm2. The effect of 
application of various waveforms  on the release profile of the drug were used studied. The study 
was conducted for 4 h. 3 ml of the receptor volume was sampled at regular intervals of time (15 
min during the first hour and 30 min thereafter). 3 ml of the receptor volume was replaced with 
fresh DW. The samples were then analyzed spectrophotometrically using a UV-visible 
spectrophotometer (UV-3200, LabIndia, Mumbai, India) at a λmax of 294 nm. 
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Figure 10: Experimental setup of iontophoretic drug delivery system 
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Chapter 4 
Results and discussion 
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4.1. Waveform generator circuit development 
The basic waveforms (Amplitude: 3.00 Vpp; Frequency: 440 Hz) were generated using computer 
controlled SPEEDY-33. The LABVIEW 8.6 was used for controlling the hardware. The 
LABVIEW program used for the generation of the basic waveforms (e.g. sine, square and 
triangular) has been shown in figure 9. The generated basic wave forms on front panel of the 
LABVIEW have been given in figure 10. The duty cycle of the square wave was 50%. The 
output of the SPEEDY-33 was fed into the voltage buffer. The output of the voltage buffer was 
same as that of its input due to the unity gain of the circuit [17]. The voltage buffer was used to 
provide protection to the SPEEDY-33. The output of voltage buffer (figure 11) was fed into the 
SCCs which modulated the basic signals being generated. The modulated signals have been 
shown in figure 12. The modulated signals (table 3) served as the input for the CCS.The 
modulated signals were generated with the help of SSC. The sine waveform was passed through 
the half wave rectifier circuit and the modulated signal was generated as a half wave rectified of 
sinusoidal waveform. While sine waveform was passed through the full wave rectifier circuit 
then modulated signal was generated as full wave rectified signal of the sinusoidal waveform. 
The square waveform was passed through the half wave rectifier circuit then the modulated 
signal was generated as pulse DC of square waveform.  
Table 2: Basic waveforms  
Basic waveform Amplitude of 
basic 
waveform 
(Vpp) 
Frequency of 
basic 
waveform 
(Hz) 
Signal 
conditioning 
circuit 
Modulated 
waveform 
Sinusoidal 3.00 440 -- SN 
Square 3.00 440 -- SQ 
Triangular 3.00 440 -- TR 
Sinusoidal 3.00 440 Half-wave rectifier SNH 
Square 3.00 440 Half-wave rectifier SQH (pulsed DC) 
Sinusoidal 3.00 440 Full-wave rectifier SNF 
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Figure 11: The LABVIEW programme for generation of basic wave forms 
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Figure 12: LabVIEW programme generated basic waveforms: (a) SN, (b) SQ, and (c) TR 
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Figure 13: Output waveforms of the voltage buffer: a) SN, (b) SQ, and (c) TR 
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Figure 14: Output waveform of the signal conditioning circuit: (a) SN, (b) SQ, and (c) TR 
(d) SNH (e) SQH and (f) SNF 
4.2. Stability of constant current source 
The stability of constant current source was checked by the varying the load resistance of 
constant current source and measured the output voltage across it. The output voltage was 
measured at every stage by changing the load resistance. The output voltage has been shown in 
the table 4.The constant current source was saturated when the load resistance was more than 6.0 
MΩ. The graph was plotted between the output peak to peak voltage (Pk-Pk) and load resistance 
(MΩ). The graph has been shown in figure 13. 
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Table 3: stability of constant current source 
Load resistance (MΩ) Output voltage (Pk-Pk) 
1 5.12 
2 5.16 
3 5.2 
4 5.25 
5 5.26 
6 5.28 
  
Figure 15: Stability of the CCS 
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4.3. Preparation of organogels 
The solution of SM-PM mixture in SO was light brown in color. Addition of DW resulted in the 
formation of yellowish white or milky white colored semi-solid formulations (figure 14). The 
formation of organogels was confirmed by inverted test-tube method [18]. The formulations 
were regarded as organogels if they did not flow under gravity (figure15) (table 5). Stable gels 
were formed after the incorporation of 0.5% (w/w) SA into the organogels. 
 
 
 
Table 4: The stable organogels, tested by inverted tube method 
Samples W/S atio Result 
F1 0.4 Gel formed 
F2 0.3 Gel formed 
F3 0.6 Gel formed 
F1D 0.404 Gel formed 
F2D 0.336 Gel formed 
F3D 0.606 Gel formed 
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Figure 16: Formation of organgels 
 
Figure 17: The stable organogels: (a) F1, (b) F2 and (c) F3 
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4.4. Impedance analysis 
  
  
Figure 18: Electrical properties of F1, F2 and F3 gels (a) Nyquist plot (b) frequency vs tan 
δ (c) frequency vs impedance and (d) frequency vs imaginary component 
The Nyquist plots of F1, F2 and F3 at RT have been shown in figure 20a. The intercept of the 
semicircle on the real axis gives bulk resistance of the materials. There was a decrease in the 
bulk resistance (Rb) of the organogels in the following order F2> F1>>F3. The least resistance of 
the F3 organogels may be attributed to the presence of higher proportion of water. Similarly, the 
higher resistances of F1 and F2 may be explained due to the presence of lower proportion of DW 
in these organogels. 
The frequency dependant tan δ plot has been shown in figure 20b. The organogels have shown a 
single relaxation peak. This may be was due to the ionic transport process in the bulk.[19] The 
impedance vs. frequency plot has been shown in figure 20c. It was seen that F2 had the highest 
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impedance as compared to F1 and F3 and was in accordance with the bulk resistances of the 
organogels obtained from the Nyquist plot. The results showed that there was a decrease in the 
impedance of the organogels with the increase in the frequency. The variation of frequency vs. 
imaginary component of the organogels has been shown in Figure 20d. The relaxation time of 
the organogels (table 8) was calculated from the following equation (2): 
max2 f 1m      (2) 
where, 
f max= frequency at Z” max. 
τm = Relaxation time  
 
It was observed that the relaxation time (τm ) of F3 was maximum as compared to F1 and F2. 
This might be associated with the presence of high water content F3. This resulted  which led to 
the increased mobility of the charged particles within the gel systems [20]. 
Table 5: Bulk resistance and relaxation time of the organogels 
Samples Bulk resistance (Rb) (Ω) Relaxation time (Hz
-1
) 
F1 96241.6704 3907.93 
F2 119697.912 3848.426 
F3 19831.1861 29891.94 
4.5 In vitro drug release studies: 
The in vitro drug release profiles from the organogels under different patterns of injected current 
have been in figure 26. The height and diameter of the donor chamber was 3.62 cm and 2.5 cm, 
respectively. 15 g of organogel was used for the study. The drug release studies suggested that 
the cumulative percent drug release (CPDR) from the organogels were higher when electrical 
current was applied as compared to the passive diffusion. The effect of the applied waveform 
shapes on the release of the drug has been tabulated in table 14. Under the experimental 
conditions, the triangular waveform and the pulsed DC have enhanced the drug release to the 
greatest extent (table 15). .In general, the effect of current on the release of the drug was more in 
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F1D and F2D as compared to F3D organogels. This may be due to the higher firmness of F3D 
which might have restricted the movement of drug molecules.  
The drug release kinetics was predicted by best-fit model estimation. Data fitting was performed 
upon the 60 % of the total drug released. The results suggested that the release of the drug was 
found to follow Zero order kinetics under both passive and active conditions (figure 27 and table 
16). This suggested that the release of the drugs was predominantly by diffusion and the release 
was concentration independent under the experimental conditions [21-22]. The results indicated 
that the application of current of different waveform did not alter the mechanism of drug release 
but only facilitated the active diffusion of the drug.  
The Krossmeyer-Peppas (KP) release exponent (n) value was calculated from the slope of the KP 
model (figure 28). The n was found to be ≥1 in most of the cases (table 16). The results indicated 
that Case-II or super Case-II transport phenomena by the drug molecules. This kind of 
phenomena happen when the diffusion of the drugs are much faster as compared to the relaxation 
of the polymer molecules of the delivery matrices [23]. In some cases, the n value was found to 
be greater than 0.85. This suggested that the release of the drugs from these matrices followed 
anomalous release behavior. The increase in the CPDR values when an electric current was 
applied was more prominent in F1D followed by F2D and F3D. 
Table 6: The CPDR values of organogels 
Type of wave form CPDR values 
F1D F2D F3D 
Passive diffusion  17.5 14.16 24.2 
SN 25.67 18.18 28.01 
SQ 30.40 16.87 31.64 
TR 27.13 29.80 32.18 
SNH 21.16 32.36 32.16 
SQH 24.87 26.82 34.95 
SNF 24.44 22.37 39.65 
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Table 7: The % increase in CPDR due to iontophoresis over passive drug delivery 
Type of wave form F1D F2D F3D 
SN 46.68 28.39 15.74 
SQ 73.71 19.13 30.74 
TR 55.02 110.45 32.97 
SNH 20.91 128.53 32.89 
SQH 42.11 89.40 44.42 
SNF 39.65 57.98 63.84 
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Figure 19: The in vitro drug delivery profiles under (a) passive diffusion and (b) SN, (c) SQ 
(d) TR (e) SNH (f) SQH and (g) SNF wave forms. 
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Figure 20: The zero order kinetics of in vitro drug delivery under (a) passive diffusion and 
(b) SN, (c) SQ, and (d) TR (e) SNH (f) SQH and (g) SNF wave forms. 
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Figure 21: The KP kinetics of in vitro drug delivery under (a) passive diffusion and (b) SN, 
(c) SQ, and (d) TR (e) SNH (f) SQH and (g) SNF wave forms. 
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Table 8: The drug release kinetics 
Wave form Sample code Zero order 
(r
2
) 
Higuchi 
(r
2
) 
KP Best fit model 
(r
2
) n 
Pas F1D 0.9791 0.9791 0.99 0.9284 Zero order  
F2D 0.9921 0.8687 0.99 0.9475 Zero order  
F3D 0.9982 0.8679 0.99 1.0014 Zero order  
SN F1D 0.99 0.8096 0.99 1.0931 Zero order 
F2D 0.9988 0.8585 0.99 1.0272 Zero order  
F3D 0.9931 0.8804 0.99 0.9883 Zero order  
SQ F1D 0.9989 0.8018 0.95 1.214 Zero order 
F2D 0.9962 0.8386 0.99 1.13 Zero order  
F3D 0.974 0.9173 0.99 0.8954 Zero order  
TR F1D 0.9944 0.8434 0.98 1.1054 Zero orde  
F2D 0.9956 0.8059 0.99 1.14 Zero order  
F3D 0.9795 0.7957 0.97 1.37 Zero order  
SQH F1D 0.9953 0.8617 0.99 1.0818 Zero order  
F2D 0.9961 0.8786 0.99 1.0272 Zero order  
F3D 0.9391 0.9096 0.97 0.9284 Zero order  
SNH F1D 0.9865 0.9085 0.99 0.8477 Zero order  
F2D 0.9982 0.8367 0.99 1.0053 Zero order  
F3D 0.9931 0.8126 0.99 1.10 Zero order  
SNF F1D 0.9968 0.8493 0.99 1.094 Zero order  
F2D 0.9871 0.8999 0.98 0.9228 Zero order  
F3D 0.9953 0.8312 0.99 1.0937 Zero order 
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5. Conclusion 
In the current study, a computer controlled iontophoretic drug delivery system was successfully 
developed. The system was tested by using span 80-Tween 80 based sunflower oil containing 
organogels. SA was used as the model drug during the study. The in vitro SA release was 
performed under different wave forms and compared against passively diffused drug across the 
in built iontophoretic set up. Potential enhancement of CPDR under the influence of current was 
seen against passively diffused drug. The results suggested that the developed iontophoretic set 
up has potential application in the iontophoretic drug delivery system. 
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